Abstract
Introduction
Gastro-esophageal reflux disease (GERD) is the most common disease of the esophagus, affecting up to 40% of adults in the USA [1, 2] . Typical symptoms of GERD include heartburn, abdominal discomfort, dysphagia, belching and acid regurgitation [3] . About 75-80% of patients with GERD report occurrence of their symptoms at night [4, 6] . Heartburn and other gastro-esophageal reflux disease (GERD) symptoms experienced during the night commonly cause sleep disturbances, including arousal from sleep, increased wakefulness, and overall poor sleep quality [7, 8] . Research also indicated that patients with dyspepsia or heartburn had higher scores in terms of anxiety, depression, and other psychiatric symptoms [9] . However, the role of sleep in the clinical presentation of gastro-esophageal reflux disease (GERD) has been largely ignored.
In the present study, we aimed to compare sleep disturbances in patients with GERD with the patients under treatment in oncology department, since little is also known about sleep quality in the people with cancer, whereas sleep disturbance is one of the most common symptoms in patients with malignancy [10] [11] [12] [13] [14] [15] [16] . Anxiety and depression, known as the most common factors influencing sleep quality, are also the most prevalent psychiatric disorders faced by patients with malignancy [17, 18] . Keeping these in mind, we evaluated sleep quality in the patients with the GERD by comparison of their sleep quality scores with those of patients with malignancy, which themselves were reported to have sleep problems.
Method
The study was approved by the local research ethic committee of the university and was carried out in one month's period during which the psychology students underwent training at the psychiatry department of the university hospital. They interviewed with fifty-four patients. Six patients were excluded from the study because their physical disabilities could not allow to effectively communicating with the students. Thus, forty-eight patients were included in the study, 22 of them were recruited from the oncology department and 26 from the gastroenterology department. The patients from the gastroenterology department were chosen for the study according to the results of endoscopy carried out by an experienced understand the study conditions and to report on their health status. As a result, the inclusion criteria of gastroenterology patients (GEPs) were that they have a positive endoscopy result regarding gastro-esophageal reflux disease (GERD), while for the oncology outpatients (OnPs) there were no exclusion criteria, except that they are willing and healthy enough to give information. Senior psychology students made face-to-face interviews with the patients in order to obtain the whole study data. They received the verbal informed consent of the patients after explaining the study process in detail, and they gave the scales used in the study.
The Turkish versions of the Hospital Anxiety and Depression (HAD) scale [19, 20] and the Pittsburgh Sleep Quality Index (PSQI) [21, 22] were administered to the patients for assessing their anxiety and depression levels and their subjective sleep quality. Quantitative data are
given as mean ± SD. The two study groups were compared by χ 2 tests in terms of categorical variables and by t tests in terms of continuous variables. Pearson's correlation coefficients and linear regression were used to examine the relationship between the PSQI scores and other demographic and clinical variables.
Results
Fifty-nine per cent of oncology patients (OnPs) were female while this rate was 64% in gastroenterology patients (GEPs) (χ 2 = .11, p>.05). The average ages of OnPs were 57. p>.05 and χ 2 = .57; p>.05, respectively). Education, disease duration, and scores on the scales administered to the patients are shown in Table- 1. There appeared no significant difference between two groups regarding anxiety and depression scores of the patients and their total sleep quality scores. Although statistically insignificant, it has been found that GEPs had higher anxiety scores than OnPs, whereas OnPs had higher depression scores than GEPs. In order to examine the factors that are likely to affect total sleep quality, a correlation analysis was applied to the whole group (Table-2 ). According to these analyzes, total sleep scores were found to be correlated only with anxiety scores of the patients (r=.34).
A multiple correlation analysis (Pearson correlation analysis), where variables with high levels of correlations and type of disease were admitted as independent variables and sleep quality as dependent variable, was applied to both of groups. The results demonstrated that sleep quality scores are determined only by anxiety scores and that whether any patient is at a certain age/gender, and has GERD or malignancy have no effect on total sleep quality scores (Table-3 ). 
Discussion
Research demonstrated that heartburn and other gastro-esophageal reflux disease (GERD) symptoms experienced during the night commonly cause sleep disturbances and that patients with dyspepsia or heartburn scored higher with regard to anxiety and depression. In addition, some studies have suggested that psychological factors such as anxiety and depression play a part in the development of GERD [23, 24] . In the present study, however, we did neither find any significant difference in the total sleep quality scores of the two group of patients, nor in their anxiety and depression scores. The only statistically significant result between the two groups is that GEPs had higher anxiety scores than OnPs. In addition, the oncology patients had a little higher depression scores on the HAD scale than GERD patients, although this reasonably conclude that presence of anxiety should also suggest additional sleep problems in both psychiatric and medical patients and that they should also be assessed in this respect.
The present study has clearly several limitations yet, resulting from mainly small sample sizes of both patient groups. Additionally, the data were based on patients' self-reported experience of sleep problems over the previous four weeks, and they do not imply clinical diagnoses, nor reflect sleep laboratory measures. Second, the cross-sectional survey design does not provide direct information about the course of sleep problems over time. Third, the types of malignancies have not been classified, although these may contribute to the mood and sleeping of the patients. Nonetheless, we can make some modest inferences on the study findings. For instance, it may be suggested that anxiety and sleeping difficulties may coexist with or without having causal relationships. Moreover, anxiety may also contribute to insomnia in patients. Therefore, it is likely that sleep problems may be better addressed as an independent variable and treated as such. It is clear that we need future longitudinal studies designed prospectively, incorporating comprehensive sleep assessment at set intervals, in order to determine the course of insomnia at different stages in the disease trajectory.
Nevertheless, knowledge of the nature and prevalence of sleep problems between these two groups of patients can provide the basis for new approaches to supportive care, because many sleep problems can be effectively treated. 
